PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24796327-10	2014	CONCLUSIONS: Topical bromfenac can penetrate into the retinochoroidal tissues in high enough concentrations to inhibit COX-2 and exerts its inhibitory effect on the blood-retinal barrier breakdown in an experimental retinochoroidal inflammation in rabbits.	bromfenac	21-30	cytochrome c oxidase subunit II	Oryctolagus cuniculus	119-124	
21351868-11	2011	Aqueous and ICB bromfenac levels exceeded its IC(50) for COX-2 at peak and trough, but not for COX-1 at trough aqueous levels and peak and trough ICB levels.	bromfenac	16-25	cytochrome c oxidase subunit II	Oryctolagus cuniculus	57-62	
32209318-3	2020	Bromfenac has shown promise in inhibiting the COX-2 enzymatic pathway that partially causes the inflammatory cascade which contributes to the precipitation of DME.	bromfenac	0-9	cytochrome c oxidase subunit II	Oryctolagus cuniculus	46-51	
16846546-11	2006	CONCLUSIONS: Ketorolac is relatively COX-1 selective while bromfenac is potently selective for COX-2 over COX-1.	bromfenac	59-68	cytochrome c oxidase subunit II	Oryctolagus cuniculus	95-100